Capitolis Liquid Global Markets LLC Makes New Investment in Corteva, Inc. $CTVA

Capitolis Liquid Global Markets LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 333,627 shares of the company’s stock, valued at approximately $22,363,000.

A number of other hedge funds have also modified their holdings of CTVA. JPL Wealth Management LLC bought a new position in shares of Corteva during the third quarter worth about $25,000. Bank of Jackson Hole Trust bought a new position in shares of Corteva during the fourth quarter worth about $28,000. Redmont Wealth Advisors LLC bought a new position in shares of Corteva during the third quarter worth about $29,000. Cornerstone Financial Management LLC bought a new position in shares of Corteva during the fourth quarter worth about $29,000. Finally, Jackson Grant Investment Advisers Inc. grew its holdings in shares of Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after buying an additional 213 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Get Corteva alerts:

Corteva Stock Performance

Shares of NYSE CTVA opened at $77.45 on Thursday. The stock has a 50 day moving average price of $79.88 and a 200 day moving average price of $75.59. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a market capitalization of $51.80 billion, a PE ratio of 45.56, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the firm posted $1.13 earnings per share. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is 42.35%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Argus increased their price objective on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Jefferies Financial Group increased their price objective on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Mizuho increased their price objective on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. BNP Paribas Exane increased their price objective on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Finally, Oppenheimer increased their price objective on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $88.81.

Get Our Latest Analysis on Corteva

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Read More

• Five stocks we like better than Corteva
• Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
• CoreWeave Insider Sales Look Big, But Should Investors Worry?
• Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
• Meta and Cloud Computing: Real Potential, or a Shot in the Dark?

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.